| Status: Medicine does not meet criteria for AWMSG assessment | |
Decision not to appraise: minor SPC update with no change to licensed indication |
|
Medicine details |
|
| Medicine name | insulin detemir (Levemir®) |
| Formulation | 100 units/ml solution for injection |
| Reference number | 1443 |
| Indication | Treatment of diabetes mellitus in adults, adolescents and children as add-on therapy to liraglutide treatment |
| Company | Novo Nordisk Ltd |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 10/05/2012 |